Current News C2i Genomics (Life Sciences, 19-20 Cohort) will be acquired by Veracyte for up to $95M Posted on January 9, 2024January 9, 2024 by Cort Meyerson 09 Jan Cort Meyerson Interface Biosciences has secured $3 million in an oversubscribed seed funding round to advance its AI drug discovery platform for inflammatory disease QSM Diagnostics signed a national distribution agreement with MWI Animal Health.